Donna L. LaVoie is President and Chief Executive Officer of LaVoieHealthScience.
Stories by Donna LaVoie
| • | The Biopharma Communications Balancing Act(Healthcare PR) Wed., Nov. 4, 2020
|
Nuanced skills are prerequisites for success as companies move from development to commercialization.| • | Coordinating Messages When Companies Join Forces(Healthcare PR) Wed., Oct. 11, 2017
|
As Pharma, biotech and health technology companies partner, the practice of integrated communications and coordinating messaging among and between all parties involved takes on mission critical importance. (1 reader comment)| • | Planning Rare Disease Communications Programming(Healthcare PR) Wed., Nov. 2, 2016 When planning orphan disease drug communication programs, it’s essential to recognize special characteristics of the rare disease environment. (1 reader comment) |
| • | PR Strategies for IPO Preparation(Financial PR & Investor Relations) Wed., Oct. 28, 2015 When companies plan to go public, establishing a communications process where PR/IR teams play a significant role in the beginning is essential to the process’ success. |
